Breast Cancer Prognostic Biomarkers: Transcriptome & Proteome Analysis

Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.

Integrating SWATH-MS Proteomics and Transcriptome Analysis Identifies CHI3L1 as a Plasma Biomarker for Early Gastric Cancer: Molecular Therapy - Oncolytics

Harnessing the modified proteome for increased diagnostic power - Drug Discovery World (DDW)

Integrated Transcriptomics–Proteomics Analysis Identifies Molecular Phenotypic Alterations Associated with Colorectal Cancer

Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models? - Computational and Structural Biotechnology Journal

Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches [PeerJ]

Biomarkers in drug discovery and development

Revolutionary Cancer Research Breakthroughs

Breast cancer quantitative proteome and proteogenomic landscape

Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma - Wei - 2023 - Cancer Medicine - Wiley Online Library

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy - ScienceDirect

Proteomes, Free Full-Text

Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers: Molecular Therapy